カテゴリ： Allied Market Research, 世界, 医療/バイオ

銀含有創傷被覆材のグローバル市場（2021〜2031）：シート状、ゲル・クリーム状、フォーム状、その他

■ 英語タイトル：Silver Wound Dressings Market By Product Type (Sheets, Gels and Creams, Foams, Others), By Treatment (Surgical Wounds, Burns, Ulcers, Lacerations and Cuts, Skin Grafts, Others), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Homecare): Global Opportunity Analysis and Industry Forecast, 2021-2031

調査会社Allied Market Research社が発行したリサーチレポート（データ管理コード：ALD23FB160）■ 発行会社/調査会社：Allied Market Research
■ 商品コード：ALD23FB160
■ 発行日：2022年10月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：239
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥542,640見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥870,960見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,459,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[銀含有創傷被覆材のグローバル市場（2021〜2031）：シート状、ゲル・クリーム状、フォーム状、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Allied Market Research社の本市場調査レポートでは、2021年に889.1百万ドルであった世界の銀含有創傷被覆材市場規模が、2031年までに1,511.8百万ドルに到達し、2022年から2031年にかけてCAGR（年平均成長率）5.4%で成長すると予測しています。本レポートは、銀含有創傷被覆材の世界市場を総合的に調査・分析した資料であり、イントロダクション、エグゼクティブサマリー、市場概要、製品別（シート状、ゲル・クリーム状、フォーム状、その他）分析、治療別（手術創、やけど、潰瘍、裂傷・切り傷、その他）分析、エンドユーザー別（病院・診療所、外来手術センター、在宅医療）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）分析、企業状況、企業情報などを掲載しています。また、本レポートは、3M Company、Argentum Medical LLC、, B Braun Melsungen AG、Convatec, Inc.、Ferris Mfg.Corp、Johnson And Johnson、Monlycke Health Careなどの企業情報を含んでいます。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の銀含有創傷被覆材市場規模：製品別
- シート状銀含有創傷被覆材の市場規模
- ゲル・クリーム状銀含有創傷被覆材の市場規模
- フォーム状銀含有創傷被覆材の市場規模
- その他の市場規模
・世界の銀含有創傷被覆材市場規模：治療別
- 手術創における市場規模
- やけどにおける市場規模
- 潰瘍における市場規模
- 裂傷・切り傷における市場規模
- その他における市場規模
・世界の銀含有創傷被覆材市場規模：エンドユーザー別
- 病院・診療所における市場規模
- 外来手術センターにおける市場規模
- 在宅医療における市場規模
・世界の銀含有創傷被覆材市場規模：地域別
- 北米の銀含有創傷被覆材市場規模
- ヨーロッパの銀含有創傷被覆材市場規模
- アジア太平洋の銀含有創傷被覆材市場規模
- 中南米・中東・アフリカの銀含有創傷被覆材市場規模
・企業状況
・企業情報

銀含有創傷被覆材の世界市場は、2021年に8億8910万ドル、2031年には15億1180万ドルに達すると予測され、2022年から2031年までの年平均成長率は5.4%となる見込みです。
銀含有創傷被覆材は、銀と一体化した抗菌被覆材です。銀は、イオン化した状態で抗真菌・抗菌特性を発揮し、病原性細菌によるバイオフィルム形成を防ぐために創傷被覆材に使用されます。さらに、これらの創傷被覆材は、低滲出液から高滲出液の創傷、潰瘍、熱傷に対して抗菌作用を発揮します。

市場の成長を促進する主な要因は、スポーツ関連の怪我や交通事故の増加、高齢者人口の増加、外科手術の急増などです。例えば、国際糖尿病連合によると、2021年には約5億3,700万人の成人（20～79歳）が糖尿病を患っています。糖尿病患者の総数は、2030年には6億4,300万人、2045年には7億8,300万人に増加すると予測されています。さらに、120万人以上の子供と青少年（0～19歳）が1型糖尿病と共存し、5億4,100万人の成人が2型糖尿病を発症するリスクが高まっていると推定されています。

さらに、抗菌性、治癒時間の短縮、感染リスクの低下など、銀を組み込んだ創傷被覆材の有益な特性に対する意識の高まりが、市場の成長を後押しする主な要因となっています。
しかし、銀の創傷ケアのコストが高いことが市場の成長を妨げると予想されます。一方、高齢者人口の増加、先進的な創傷治療に対する意識の高まり、発展途上国における高成長オプションは、予測期間中の市場成長に有利な機会を提供すると予想されます。

銀含有創傷被覆材市場は、製品タイプ、治療法、エンドユーザー、地域によって区分されます。製品タイプ別では、シート、ジェル＆クリーム、フォーム、その他に分類されます。ジェル＆クリームはさらにアルギン酸、ハイドロゲル、スルファジアジン銀、その他に分類されます。治療別では、潰瘍、皮膚移植、裂傷・切り傷、手術創、熱傷、その他に分類されます。エンドユーザー別では、病院・診療所、外来手術センター、在宅医療に分けられます。地域別では、北米、欧州、アジア太平洋、LAMEAに市場を分けて分析しています。

北米は2021年の銀含有創傷被覆材市場シェアの大半を占め、予測期間中も支配的な地位を維持すると予測されています。同市場の主な原動力は、確立された医療施設が存在すること、糖尿病や慢性・急性創傷の有病率が高いことです。さらに、技術的に高度な製品を開発するための研究開発活動に携わる数多くの主要企業が存在することも、この地域の市場成長に寄与しています。

アジア太平洋地域は、予測期間中に最も速いCAGRを記録する見込みです。これは、高齢者人口の多さと医療インフラの絶え間ない改善によるものです。さらに、人口の急増、外科手術の件数や交通事故の増加が、アジア太平洋地域の市場成長を促進すると考えられます。

銀含有創傷被覆材市場で事業を展開する主要企業には、3M (Acelity Inc.)、Medline Industries, LP、Argentum Medical LLC、B. Braun Melsungen AG、Convatec Inc、Dermarite Industries, Inc、Ferris Mfg. Corp.、Johnson and Johnson、Molnlycke Health Care AB、Smith and Nephew PLCなどがあります。

〈ステークホルダーにとっての主なメリット〉
・本レポートは、2021年から2031年までの銀含有創傷被覆材市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、銀含有創傷被覆材市場の優勢な機会を特定します。
・銀含有創傷被覆材市場の主要な促進要因、阻害要因、機会に関する情報を提供します。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
・銀含有創傷被覆材市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
・各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・銀含有創傷被覆材の地域別および世界市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

〈主要市場セグメント〉
製品タイプ別
シート
ジェル＆クリーム
フォーム
その他

治療別
手術創
やけど
潰瘍
裂傷＆切り傷
皮膚移植
その他

エンドユーザー別
病院＆診療所
外来手術センター
在宅医療

地域別
・北米
米国
カナダ
メキシコ
・ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
・アジア太平洋
日本
中国
オーストラリア
インド
韓国
その他のアジア太平洋地域
・LAMEA
ブラジル
サウジアラビア
南アフリカ
その他のLAMEA地域

〈主要市場プレイヤー〉
3M Company
Argentum Medical LLC
B Braun Melsungen AG
Convatec, Inc.
Ferris Mfg.Corp
Johnson And Johnson
Mölnlycke Health Care
medline industries, inc.
DermaRite Industries, LLC.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Sheets
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3 Gels and Creams
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
4.3.4 Gels and Creams Silver Wound Dressings Market by Type
4.4 Foams
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market share analysis by country
4.5 Others
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market share analysis by country
CHAPTER 5: SILVER WOUND DRESSINGS MARKET, BY TREATMENT
5.1 Overview
5.1.1 Market size and forecast
5.2 Surgical Wounds
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3 Burns
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
5.4 Ulcers
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market share analysis by country
5.5 Lacerations and Cuts
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market share analysis by country
5.6 Skin Grafts
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market share analysis by country
5.7 Others
5.7.1 Key market trends, growth factors and opportunities
5.7.2 Market size and forecast, by region
5.7.3 Market share analysis by country
CHAPTER 6: SILVER WOUND DRESSINGS MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals and Clinics
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.3 Ambulatory Surgical Centers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country
6.4 Homecare
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market share analysis by country
CHAPTER 7: SILVER WOUND DRESSINGS MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product Type
7.2.3 North America Market size and forecast, by Treatment
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Key market trends, growth factors and opportunities
7.2.5.1.2 Market size and forecast, by Product Type
7.2.5.1.3 Market size and forecast, by Treatment
7.2.5.1.4 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Key market trends, growth factors and opportunities
7.2.5.2.2 Market size and forecast, by Product Type
7.2.5.2.3 Market size and forecast, by Treatment
7.2.5.2.4 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Key market trends, growth factors and opportunities
7.2.5.3.2 Market size and forecast, by Product Type
7.2.5.3.3 Market size and forecast, by Treatment
7.2.5.3.4 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product Type
7.3.3 Europe Market size and forecast, by Treatment
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Key market trends, growth factors and opportunities
7.3.5.1.2 Market size and forecast, by Product Type
7.3.5.1.3 Market size and forecast, by Treatment
7.3.5.1.4 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Key market trends, growth factors and opportunities
7.3.5.2.2 Market size and forecast, by Product Type
7.3.5.2.3 Market size and forecast, by Treatment
7.3.5.2.4 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Key market trends, growth factors and opportunities
7.3.5.3.2 Market size and forecast, by Product Type
7.3.5.3.3 Market size and forecast, by Treatment
7.3.5.3.4 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Key market trends, growth factors and opportunities
7.3.5.4.2 Market size and forecast, by Product Type
7.3.5.4.3 Market size and forecast, by Treatment
7.3.5.4.4 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Key market trends, growth factors and opportunities
7.3.5.5.2 Market size and forecast, by Product Type
7.3.5.5.3 Market size and forecast, by Treatment
7.3.5.5.4 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Key market trends, growth factors and opportunities
7.3.5.6.2 Market size and forecast, by Product Type
7.3.5.6.3 Market size and forecast, by Treatment
7.3.5.6.4 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product Type
7.4.3 Asia-Pacific Market size and forecast, by Treatment
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Key market trends, growth factors and opportunities
7.4.5.1.2 Market size and forecast, by Product Type
7.4.5.1.3 Market size and forecast, by Treatment
7.4.5.1.4 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Key market trends, growth factors and opportunities
7.4.5.2.2 Market size and forecast, by Product Type
7.4.5.2.3 Market size and forecast, by Treatment
7.4.5.2.4 Market size and forecast, by End User
7.4.5.3 Australia
7.4.5.3.1 Key market trends, growth factors and opportunities
7.4.5.3.2 Market size and forecast, by Product Type
7.4.5.3.3 Market size and forecast, by Treatment
7.4.5.3.4 Market size and forecast, by End User
7.4.5.4 India
7.4.5.4.1 Key market trends, growth factors and opportunities
7.4.5.4.2 Market size and forecast, by Product Type
7.4.5.4.3 Market size and forecast, by Treatment
7.4.5.4.4 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Key market trends, growth factors and opportunities
7.4.5.5.2 Market size and forecast, by Product Type
7.4.5.5.3 Market size and forecast, by Treatment
7.4.5.5.4 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Key market trends, growth factors and opportunities
7.4.5.6.2 Market size and forecast, by Product Type
7.4.5.6.3 Market size and forecast, by Treatment
7.4.5.6.4 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product Type
7.5.3 LAMEA Market size and forecast, by Treatment
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Key market trends, growth factors and opportunities
7.5.5.1.2 Market size and forecast, by Product Type
7.5.5.1.3 Market size and forecast, by Treatment
7.5.5.1.4 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Key market trends, growth factors and opportunities
7.5.5.2.2 Market size and forecast, by Product Type
7.5.5.2.3 Market size and forecast, by Treatment
7.5.5.2.4 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Key market trends, growth factors and opportunities
7.5.5.3.2 Market size and forecast, by Product Type
7.5.5.3.3 Market size and forecast, by Treatment
7.5.5.3.4 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Key market trends, growth factors and opportunities
7.5.5.4.2 Market size and forecast, by Product Type
7.5.5.4.3 Market size and forecast, by Treatment
7.5.5.4.4 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 3M Company
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Argentum Medical LLC
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 , B Braun Melsungen AG
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Convatec, Inc.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Ferris Mfg.Corp
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Johnson And Johnson
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Monlycke Health Care
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Mölnlycke Health Care
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 medline industries, inc.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 DermaRite Industries, LLC.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 2. SILVER WOUND DRESSINGS MARKET FOR SHEETS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 3. SILVER WOUND DRESSINGS MARKET FOR SHEETS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 4. SILVER WOUND DRESSINGS MARKET FOR GELS AND CREAMS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 5. SILVER WOUND DRESSINGS MARKET FOR GELS AND CREAMS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 6. GLOBAL GELS AND CREAMS SILVER WOUND DRESSINGS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 7. SILVER WOUND DRESSINGS MARKET FOR FOAMS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 8. SILVER WOUND DRESSINGS MARKET FOR FOAMS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 9. SILVER WOUND DRESSINGS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 10. SILVER WOUND DRESSINGS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 11. GLOBAL SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 12. SILVER WOUND DRESSINGS MARKET FOR SURGICAL WOUNDS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 13. SILVER WOUND DRESSINGS MARKET FOR SURGICAL WOUNDS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 14. SILVER WOUND DRESSINGS MARKET FOR BURNS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 15. SILVER WOUND DRESSINGS MARKET FOR BURNS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 16. SILVER WOUND DRESSINGS MARKET FOR ULCERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 17. SILVER WOUND DRESSINGS MARKET FOR ULCERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 18. SILVER WOUND DRESSINGS MARKET FOR LACERATIONS AND CUTS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 19. SILVER WOUND DRESSINGS MARKET FOR LACERATIONS AND CUTS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 20. SILVER WOUND DRESSINGS MARKET FOR SKIN GRAFTS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 21. SILVER WOUND DRESSINGS MARKET FOR SKIN GRAFTS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 22. SILVER WOUND DRESSINGS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 23. SILVER WOUND DRESSINGS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 24. GLOBAL SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 25. SILVER WOUND DRESSINGS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 26. SILVER WOUND DRESSINGS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 27. SILVER WOUND DRESSINGS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 28. SILVER WOUND DRESSINGS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 29. SILVER WOUND DRESSINGS MARKET FOR HOMECARE, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 30. SILVER WOUND DRESSINGS MARKET FOR HOMECARE, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 31. SILVER WOUND DRESSINGS MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 32. NORTH AMERICA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 33. NORTH AMERICA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 34. NORTH AMERICA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 35. NORTH AMERICA SILVER WOUND DRESSINGS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 36. U.S. SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 37. U.S. SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 38. U.S. SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 39. CANADA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 40. CANADA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 41. CANADA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 42. MEXICO SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 43. MEXICO SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 44. MEXICO SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 45. EUROPE SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 46. EUROPE SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 47. EUROPE SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 48. EUROPE SILVER WOUND DRESSINGS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 49. GERMANY SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 50. GERMANY SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 51. GERMANY SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 52. FRANCE SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 53. FRANCE SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 54. FRANCE SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 55. UK SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 56. UK SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 57. UK SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 58. ITALY SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 59. ITALY SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 60. ITALY SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 61. SPAIN SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 62. SPAIN SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 63. SPAIN SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 64. REST OF EUROPE SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 65. REST OF EUROPE SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 66. REST OF EUROPE SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 67. ASIA-PACIFIC SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 68. ASIA-PACIFIC SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 69. ASIA-PACIFIC SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 70. ASIA-PACIFIC SILVER WOUND DRESSINGS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 71. JAPAN SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 72. JAPAN SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 73. JAPAN SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 74. CHINA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 75. CHINA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 76. CHINA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 77. AUSTRALIA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 78. AUSTRALIA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 79. AUSTRALIA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 80. INDIA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 81. INDIA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 82. INDIA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 83. SOUTH KOREA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 84. SOUTH KOREA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 85. SOUTH KOREA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 86. REST OF ASIA-PACIFIC SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 87. REST OF ASIA-PACIFIC SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 88. REST OF ASIA-PACIFIC SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 89. LAMEA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 90. LAMEA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 91. LAMEA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 92. LAMEA SILVER WOUND DRESSINGS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 93. BRAZIL SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 94. BRAZIL SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 95. BRAZIL SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 96. SAUDI ARABIA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 97. SAUDI ARABIA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 98. SAUDI ARABIA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 99. SOUTH AFRICA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 100. SOUTH AFRICA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 101. SOUTH AFRICA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 102. REST OF LAMEA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 103. REST OF LAMEA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 104. REST OF LAMEA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 105.3M COMPANY: COMPANY SNAPSHOT
TABLE 106.3M COMPANY: OPERATING SEGMENTS
TABLE 107.3M COMPANY: PRODUCT PORTFOLIO
TABLE 108.3M COMPANY: NET SALES
TABLE 109.3M COMPANY: KEY STRATERGIES
TABLE 110.ARGENTUM MEDICAL LLC: COMPANY SNAPSHOT
TABLE 111.ARGENTUM MEDICAL LLC: OPERATING SEGMENTS
TABLE 112.ARGENTUM MEDICAL LLC: PRODUCT PORTFOLIO
TABLE 113.ARGENTUM MEDICAL LLC: NET SALES
TABLE 114.ARGENTUM MEDICAL LLC: KEY STRATERGIES
TABLE 115., B BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 116., B BRAUN MELSUNGEN AG: OPERATING SEGMENTS
TABLE 117., B BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 118., B BRAUN MELSUNGEN AG: NET SALES
TABLE 119., B BRAUN MELSUNGEN AG: KEY STRATERGIES
TABLE 120.CONVATEC, INC.: COMPANY SNAPSHOT
TABLE 121.CONVATEC, INC.: OPERATING SEGMENTS
TABLE 122.CONVATEC, INC.: PRODUCT PORTFOLIO
TABLE 123.CONVATEC, INC.: NET SALES
TABLE 124.CONVATEC, INC.: KEY STRATERGIES
TABLE 125.FERRIS MFG.CORP: COMPANY SNAPSHOT
TABLE 126.FERRIS MFG.CORP: OPERATING SEGMENTS
TABLE 127.FERRIS MFG.CORP: PRODUCT PORTFOLIO
TABLE 128.FERRIS MFG.CORP: NET SALES
TABLE 129.FERRIS MFG.CORP: KEY STRATERGIES
TABLE 130.JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 131.JOHNSON AND JOHNSON: OPERATING SEGMENTS
TABLE 132.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 133.JOHNSON AND JOHNSON: NET SALES
TABLE 134.JOHNSON AND JOHNSON: KEY STRATERGIES
TABLE 135.MONLYCKE HEALTH CARE: COMPANY SNAPSHOT
TABLE 136.MONLYCKE HEALTH CARE: OPERATING SEGMENTS
TABLE 137.MONLYCKE HEALTH CARE: PRODUCT PORTFOLIO
TABLE 138.MONLYCKE HEALTH CARE: NET SALES
TABLE 139.MONLYCKE HEALTH CARE: KEY STRATERGIES
TABLE 140.MÖLNLYCKE HEALTH CARE: COMPANY SNAPSHOT
TABLE 141.MÖLNLYCKE HEALTH CARE: OPERATING SEGMENTS
TABLE 142.MÖLNLYCKE HEALTH CARE: PRODUCT PORTFOLIO
TABLE 143.MÖLNLYCKE HEALTH CARE: NET SALES
TABLE 144.MÖLNLYCKE HEALTH CARE: KEY STRATERGIES
TABLE 145.MEDLINE INDUSTRIES, INC.: COMPANY SNAPSHOT
TABLE 146.MEDLINE INDUSTRIES, INC.: OPERATING SEGMENTS
TABLE 147.MEDLINE INDUSTRIES, INC.: PRODUCT PORTFOLIO
TABLE 148.MEDLINE INDUSTRIES, INC.: NET SALES
TABLE 149.MEDLINE INDUSTRIES, INC.: KEY STRATERGIES
TABLE 150.DERMARITE INDUSTRIES, LLC.: COMPANY SNAPSHOT
TABLE 151.DERMARITE INDUSTRIES, LLC.: OPERATING SEGMENTS
TABLE 152.DERMARITE INDUSTRIES, LLC.: PRODUCT PORTFOLIO
TABLE 153.DERMARITE INDUSTRIES, LLC.: NET SALES
TABLE 154.DERMARITE INDUSTRIES, LLC.: KEY STRATERGIES

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • コルクフローリングのグローバル市場（2020～2030）：シート状、タイル状
  • クリ・デュ・チャット症候群治療のグローバル市場（2021〜2031）：理学療法、言語療法、作業療法
  • 肉腫治療薬のグローバル市場（2021〜2031）：悪性骨腫瘍、軟部肉腫
  • セルライト治療のグローバル市場（2021〜2031）：非侵襲的、低侵襲的、局所的
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(ALD23FB160 )"銀含有創傷被覆材のグローバル市場（2021〜2031）：シート状、ゲル・クリーム状、フォーム状、その他" (英文：Silver Wound Dressings Market By Product Type (Sheets, Gels and Creams, Foams, Others), By Treatment (Surgical Wounds, Burns, Ulcers, Lacerations and Cuts, Skin Grafts, Others), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Homecare): Global Opportunity Analysis and Industry Forecast, 2021-2031)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。